Frequency and risk factors for the development of infravesical obstructions caused by surgery of benign prostatic hyperplasia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Benign prostatic hyperplasia (BPH) is one of the most common diseases of men elderly and senile age. The main surgical methods of treatment for BPH are transurethral resection and open prostatectomy. In some cases surgical treatment of BPH is accompanied by the development of postoperative complications leading to recurrence of the infravesical obstruction. Currently, there are no strict guidelines for selection of an optimal method of correction of late obstructive complications. This study highlights the main existing theories concerning development of urethral strictures and bladder neck contracture.

Full Text

Restricted Access

About the authors

N. V Kriuchkova

Rostov State Medical University of the Ministry of Health of Russia

Ph.D. Student at the Department of Urology and reproductive health with Pediatric Urology and Andrology Course of the fPe and PRS

M. I Kogan

Rostov State Medical University of the Ministry of Health of Russia

Email: dept_kogan@mail.ru
Honored Scientist of the Russian Federation, Dr.Med. Sci., Prof., Head of the Department of Urology and reproductive health with Pediatric Urology and Andrology Course of the FPE and PRS

V. P Glukhov

Rostov State Medical University of the Ministry of Health of Russia

Ph.D., Associate Professor at the Department of Urology and reproductive health with Pediatric Urology and Andrology Course of the FPE and PRS

V. V Mitusov

Rostov State Medical University of the Ministry of Health of Russia

Dr.Med.Sci., Associate Professor at the Department of Urology and reproductive health with Pediatric Urology and Andrology Course of the FPE and PRS

D. V Sizyakin

Rostov State Medical University of the Ministry of Health of Russia

Dr.Med.Sci., Prof. at the Department of Urology and reproductive health with Pediatric Urology and Andrology Course of the fPe and PRS

References

  1. Биктимиров Р.Г., Мартов А.Г., Бикгимиров Т.Р., Капутовский А.А. Роль экстраперигонеоскопической аденомэктомии в оперативном лечении доброкачественной гиперплазии предстательной железы объемом более 80 см3. Урология. 2017;6:76-80
  2. Аляев Ю.Г. Винаров А.З., Чалый М.Е., Демиденко Ю.Л., Ахвледиани Н.Д. Причины эректильной дисфункции после трансуретральной резекции гиперплазированной предстательной железы и ее профилактика. Урология. 2005;3: 28-32
  3. Мартов А.Г., Ергаков Д.В. Опыт применения дутастерида пред трансуретральной резекции простаты по поводу аденомы. Урология. 2008;4:46-50
  4. Beckman T., Mynderse L. Evaluation and medical management of benign prostatic hyperplasia. Mayo Clin. Proc. 2005;80(10):1356-1362. Doi:10,4065 / 80.10.1356
  5. Parker D., Simhan J. Manegement оf complications after surgical outlet reduction for bening prostatic obstructions. Can. J. Urol. 2015;22(1):88-92.
  6. Nickel J.C., Gilling P., Tammela T.L., et al. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS). BJU Int. 2011;108(3):388-394.
  7. Kallenberg F., Hossack T.A., Woo H.H. Long-Term followup after electrocautery transurethral resection of the prostate for benign prostatic hyperplasia. Advances in Urology. 2011;2011:359-478 doi: 10.1155/2011/359478.
  8. Souverein P., Erken I., de la Rosette I., et al. Drug treatment of BPH and hospital admission for BPH related surgery. Europ. Urol. 2003;43:528-534.
  9. Камалов A.A., Гущин Б.Л., Дорофеев С.Д., Комлев Д.Л., Токарев Ф.В., Ефремов Е.А. Современные аспекты оперативного лечения доброкачественной гиперплазии предстательной железы. Урология. 2004;1:30-34
  10. Chen M.L., Correa A.F., Santucci R.A., Urethral strictures and stenoses caused by prostate therapy. Rev Urol. 2016;18(2):90-102. doi: 10.3909/riu0685.
  11. Устинов Д.В., Холтобин Д.П., Кульчавеня Е.В., Айзикович Б.И. Применение лазерной вапоризации для лечения аденомы предстательной железы. Урология. 2013;4:74-79
  12. McVary K., Roehrborn G., Avins A., Barry M., Bruskewitz R., Donnell R., Foster H., Gonzalez C., Kaplan S., Penson D., Ulchaker J., Wei J. Management of benign prostatic hyperplasia (BPH). American Urological Association guideline. 2014. http://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014).
  13. Мартов А.Г., Андронов А.С., Дутов С.В., Байков Н.А. Эякуляторно-протективная трансуретральная резекция предстательной железы. Урология. 2014;4:69-75
  14. Nickel J.C., Méndez-Probst C.E., Whelan T.F., Paterson Ryan F., Razvi H. 2010 Update: Guidelines for the management of benign prostatic hyperplasia Can. Urol. Assoc J. 2010;4(5):310-316.
  15. Rieken M., Bachmann A., Shariat S.F. Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? Curr. Opin. Urol. 2016;26(1):22-27. Doi: 10.1097/ M0U.0000000000000244.
  16. Rassweiler J., Teber D., Kuntz R., Hofmann R. Complications of transurethral resection of the prostate (TURP) - incidence, management and prevention. Eur. Urol. 2006;50:969-980. Doi: http://dx.doi.org/10.1016/j.eururo.2005.12.042.
  17. Мартов А.Г., Лопаткин Н.А. Руководство по трансуретральной электрохирургии доброкачественной гиперплазии простаты. М.: Триада Х., 1997. 114
  18. Roehborn C.G. Standard surgical interventions. In: Texbook of bening prostatic hyperplasia. Oxford: ISIS Medical Media; 1996:341-378.
  19. Камалов А.А., Осмоловский Б.Е. Трансуретральная фотоселективная лазерная вапоризация в лечении аденомы предстательной железы. Урология. 2008;5:28-31
  20. Gravas S., Bach T., Bachmann A., Drake M., Gacci M., Gratzke C., Madersbacher S., Mamoulakis C., Tikkinen K. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association ofUrology. 2016. [Electronic resource]. Режим доступа: https://uroweb.org/wp-content/uploads/EAU-Guidelines-Management-of-non-neurogenic-male-LUTS-2016-1.pdf.
  21. McVary, K.T., Roehrborn C.G., Avins A.L., Barry M.J., Bruskewitz R.C., Donnell R.F., Foster H.E. Jr, Gonzalez C.M., Kaplan S.A., Penson D.F., Ulchaker J.C., Wei J.T., Update on AUA guideline on the management of benign prostatic hyperplasia. J. Urol. 2011;185(5):1793-1803. doi: 10.1016/j.juro.2011.01.074.
  22. Rigatti P., Cestari A., Gilling P. The motion: large BPH should be treated by open surgery. Eur. Urol. 2007;51(3):845-847.
  23. Logie J.W., Clifford G.M., Farmer R.D., Meesen B.P. Lower urinary tract symptoms suggestive of benign prostatic obstruction - Triumph: the role of general practice databases. Eur. Urol. 2001;39(3):42-47.
  24. Трапезникова М.Ф., Базаев В.В., Тибилов А.С. Патогенез рецидивной инфравезикальной обструкции у больных после аденомэктомии и ТУР простаты. Материалы 2-й всероссийской конференции «Мужское здоровье». М., 2005. С. 134
  25. Мшвилдадзе Л.П. Поздние обструктивные осложнения аденомэктомии простаты. Автореф. дисс. канд. мед. наук. М., 1986
  26. Tasci A.I., Ilbey Y.O., Tugcu V., Cicekler O., Cevik C., Zoroglu F. Transurethral resection of the prostate with monopolar resectoscope: single-surgeon experience and long-term results of after 3589 procedures. Urology. 2011;78(5):1151-1155. doi: 10.1016/j.urology.2011.04.072.
  27. Fiuk J., Nuss G. R., Gonzalez C. M. Risk factors for urethral stricture and bladder neck contracture following transurethral prostatectomy for BPH/LUTS. J. Urol. 2012; 187(4):e1 doi: 10.1016/j.juro.2012.02.044.
  28. Комлев Д.Л. Отдаленные результаты оперативных методов лечения доброкачественной гиперплазии предстательной железы. Автореф. дисс. канд. мед. наук. Москва; 2004
  29. Varkarakis I., Kyriakakis Z., Delis A., Rotogerou V., Delivelioti C. Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology. 2004;64(2):306-310.
  30. Tan G.H. et al. Urethral strictures after bipolar transurethral resection of prostate may be linked to slow resection rate. Investig. Clin. Urol. 2017;58:186-191. doi: 10.4111/icu.2017.58.3.186.
  31. Hammadeh M.Y., Madaan S., Singh M., Philp A. A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy. BJU Int. 2000;86(6): 648-651.
  32. Elkoushy M.A., Elshal A.M., Elhilali V.V. Reoperation after holmium laser enucleation of the prostate for management of benign prostatic hyperplasia: assessment ofrisk factors with time to event analysis. J. Endourol. 2015;29(7):797-804. doi: 10.1089/end.2015.0060.
  33. Kuntz R.M., Lehrich K., Ahyai S.A. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year followup results of a randomised clinical trial. Eur. Urol. 2008;53:160-166. Doi: http:// dx.doi.org/10.1016/j.eururo.2010.06.005.
  34. Kitrey N.D., Djakovic N., Gonsalves M., Kuehhas F.E, Lumen N., Serafetinidis E., Sharma D.M., Summerton D.J. Guidelines on Urological Trauma. European Association of Urology. 2016. [Electronic resource]. https://uroweb.org/ wp-content/uploads/EAU-Guidelines-Urological-Trauma-2016-1.pdf.
  35. Мазо Е.Б. Поздние осложнения аденомэктомии предстательной железы, приводящие к инфравезикальной обструкции. Аденома предстательной железы: Сб. науч. тр. М.,1987;87-93
  36. Mozes B., Cohen Y.C., Olmer L., Shabtai E. Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques. J. Urol. 1996;155(1):191-196.
  37. Mearini E., Marzi M., Mearini L., Zucchi A., Porena M. Open prostatectomy in benign prostatic hyperplasia: 10-year experience in Italy. Eur Urol. 1998;34(6):480-485.
  38. Лопаткин Н.А. Доброкачественная гиперплазия предстательной железы. М., НИИ Урологии. 1999
  39. Meyhoff H., Nordling J., Hald T. Clinical evaluation of transurethral versus transvesical prostatectomy. A Randomised study. Scand. J. Urol. Nephrol. 1984;18:201-209.
  40. Tubaro A., Carter S., Hind A., Vicentini C., Miano L. A prospective study of the safetyand efficacy of suprapubic transvesical prostatectomy in patients with benignprostatic hyperplasia. J. Urol. 2001;166:172-176.
  41. Русаков В.И. Об оперативном лечении стриктур уретры. Урология и нефрология. 1965;5:37-39
  42. Великанов К.А. Новиков А.М., Фиксман Ф.Л. Стриктуры уретры после операции по поводу аденомы предстательной железы. Вопросы экспериментальной и клинической хирургии. Всесоюзный симпозиум «Диагностика и лечение стриктур уретры». Ростов-на-Дону. 1975;96-97
  43. Zwergel U. Benign prostatic hyperplasia (BPH) syndrome. Surgical and interventional therapy options. Urologe. 2001;40(4):319-328.
  44. Tao H., Jiang Y. Y., Jun Q., Ding X., Jian D. L., Jie D., Ping Z. Y. Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate. BJU Int. 2016;42(2):302-311. http://doi.org/10.1590/S1677-5538.IBJU.2014.0500.
  45. Michielsen D.P., Coomans D. Urethral strictures and bipolar transurethral resection in saline of the prostate: fact or fiction? J. Endourol. 2010;24(8):1333- 1337. doi: 10.1089/end.2009.0575.
  46. Mundy A.R., Andrich D.E., Urethral strictures. BJU Int. 2011;107(1):6-26. Doi: 10.1111 / j.1464-410X.2010.09800.x
  47. Греченков А.С., Глыбочко П.В., Аляев Ю.Г., Бутнару Д.В., Безруков Е.А., Винаров А.З., Суханов Р.Б. Факторы риска развития стриктуры уретры и/или контрактуры шейки мочевого пузыря после монополярной трансуретральной резекции гиперплазии предстательной железы. Урология. 2017;1:5-9). Doi: 10/20953/2307-6631-2017-1-5-6.
  48. Komura K., Inamoto T., Takai T., Saito K., Tanda N., Minami K., Oide R., Uehara H., Takahara K., Hirano H., Nomi H., Kiyama S., Watsuji T., Azuma H. Incidence of urethral stricture after bipolar transurethral resection of the prostate using TURis: results from a randomised trial. BJU Int. 2015;115(4):644-652. doi: 10.1111/bju.12831.
  49. Mathur R., Aggarwal G., Satsangi B., Khan F., Odiya S. Comprehensive analysis of etiology on the prognosis of urethral strictures. Int. Braz. J. Urol. 2011;3(3):362-370.
  50. Fenton A.S., Morey A.F., Aviles R., Garcia C.R: Anterior urethral strictures: etiology and characteristics. Urology. 2005;65(6):1055-1058. Doi: 10.1016/j. urology.2004.12.018
  51. Heyns C.F., Van der Merwe J., Basson J., Van der Merwe A. Etiology of male urethral strictures-Evaluation of temporal changes at a single center, and review of the literature. African. J. Urol. 2012;18(1):4-9.
  52. Lumen N., Hoebeke P., Willemsen P., De Troyer B., Pieters R., Oosterlinck W. Etiology of urethral stricture disease in the 21st century. J. Urol. 2009;182(3):983- 987. doi: 10.1016/j.juro.2009.05.023.
  53. Lee Y.H., Chiu A. W., Huang J.K., Comprehensive study of bladder neck contracture after transurethral resection of prostate. Urology. 2005;65(3):498-503. Doi:10.1016/ j.urology.2004.10.082.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies